Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Journal of Clinical Pharmacology|March 20, 1998
Lack of effect of type II diabetes on the pharmacokinetics of troglitazone in a multiple-dose studyC M Loi, E J Randinitis, A B Vassos, et al.Journal of Clinical Pharmacology|September 3, 1999
Steady-state pharmacokinetics and dose proportionality of troglitazone and its metabolitesC M Loi, C W Alvey, A B Vassos, et al.Pediatrics|January 1, 1982
Individualization of theophylline dosage using a single serum sample following a test doseG G Shapiro, J R Koup, C T Furukawa, et al.Journal of Clinical Pharmacology|April 29, 1998
Effect of troglitazone on steady-state pharmacokinetics of digoxinC M Loi, P W Knowlton, R Stern, et al.The Journal of Allergy and Clinical Immunology|October 1, 1986
Application of stable isotope methodology in the evaluation of sustained-release theophylline dosage formsJ R Koup, S B Walker, G G Shapiro, et al.Antimicrobial Agents and Chemotherapy|September 1, 1982
Piperacillin pharmacokinetics in pediatric patientsC B Wilson, J R Koup, K E Opheim, et al.Clinical Pharmacokinetics|June 8, 2000
Impact of population pharmacokinetic-pharmacodynamic analyses on the drug development process: experience at Parke-DavisS C Olson, H Bockbrader, R A Boyd, et al.Antimicrobial Agents and Chemotherapy|August 15, 2001
Clinafloxacin pharmacokinetics in subjects with various degrees of renal functionE J Randinitis, J R Koup, G Rausch, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravisG Sempowski, J Thomasch, M Gooding, et al.AIDS (London, England)|January 1, 1997
CD8+ T-cell-mediated suppression of HIV replication in the first year of life: association with lower viral load and favorable early survivalH Pollack, M X Zhan, J T Safrit, et al.Pageof 9